Akari Therapeutics was established in 2005 in the UK. The company is currently public and trades on NASDAQ under AKTX.
75/76 Wimpole Street London W1G 9RT UK
T: +44 (0)20.8004.0261
135 W 41st Street. 5th Floor New York, NY, 10036